SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Zcash is a privacy-focused cryptocurrency that uses trustless zero-knowledge proofs to enable fully encrypted transactions while maintaining blockchain transparency and security. It was the first cryptocurrency to implement zero-knowledge encryption for private peer-to-peer payments, addressing the fundamental privacy gap in traditional cryptocurrencies that expose transaction details publicly.   With a fixed supply of 21 million ZEC and a halving schedule similar to Bitcoin, Zcash allows users to prove transactions are valid without revealing sensitive information like wallet balances, transaction amounts, or participant identities, making it suitable for everyday payments, long-term savings, and cross-border money transfers where financial confidentiality matters.  The protocol operates on its own blockchain currently using Proof-of-Work consensus, though it's evolving toward Proof-of-Stake through the planned "Crosslink" upgrade to enhance security, scalability, and energy efficiency. Zcash employs trustless zero-knowledge proofs (Halo) within its Orchard shielded pool to verify transactions without revealing sender, receiver, or amount information.   Users can choose between transparent public transactions and shielded private transactions through Unified Addresses, which work with both types. The network is faster and cheaper than Bitcoin, with new blocks mined every 75 seconds and transaction fees typically just a fraction of a cent. Privacy adoption has surged in 2025, with over 30% of total ZEC supply now held in fully shielded pools.  Zcash was created by a group of scientists in 2013 who initially proposed Zerocoin as a privacy extension to Bitcoin before building a standalone protocol. The ecosystem operates with a self-funded development model where block rewards support independent teams through the Zcash Community Grants Committee and a new Coinholder-Controlled Fund.

Zcash

Zcash is rallying as traders anticipate the launch of a new exchange-traded fund, fueling speculation of increased institutional demand and liquidity. The community is largely bullish, with many viewing the asset as a privacy-focused alternative to Bitcoin, though some express caution regarding potential volatility and government oversight.

Polkadot is a platform that allows diverse blockchains to transfer messages, including value, in a trust-free fashion; sharing their unique features while pooling their security. In brief, Polkadot is a scalable heterogeneous multi-chain technology.  Polkadot is heterogeneous because it is entirely flexible and makes no assumption about the nature or structure of the chains in the network. Even non-blockchain systems or data structures can become parachains if they fulfill a set of criteria.  Polkadot may be considered equivalent to a set of independent chains (e.g. a set containing Ethereum, Ethereum Classic, Namecoin and Bitcoin) except with important additions: pooled security and trust-free interchain transactability.  Many of the native parachains of Polkadot will be written using a Polkadot Runtime Environment SDK (e.g. Parity Technologies' Substrate).

Polkadot

Polkadot is receiving attention from traders debating its long-term viability, with some expressing strong bearish sentiment regarding its price performance and perceived lack of demand, while others highlight upcoming technical upgrades and supply-cap initiatives as potential catalysts for a recovery.

ProShares Trust II - ProShares Ultra Bloomberg Crude Oil 2x Shares

ProShares Ultra Bloomberg Crude Oil

The conversation surrounding ProShares Ultra Bloomberg Crude Oil is dominated by uncertainty over the U.S.-Iran conflict and its potential impact on oil supply through the Strait of Hormuz. Traders are actively debating whether energy prices will spike due to geopolitical escalations or fall further as alternative shipping routes, increased output from non-OPEC producers, and weakening demand diminish the market's reliance on the region.

ProShares Trust - ProShares Bitcoin ETF

ProShares Bitcoin Strategy ETF

The conversation surrounding BITO is dominated by debate over the sustainability of its dividend payments amid Bitcoin's recent price volatility. Traders are divided between those accumulating shares at lower prices in anticipation of a long-term bullish cycle and those expressing frustration over declining payouts and share price erosion.

ProShares Trust - ProShares UltraPro QQQ 3x Shares

ProShares UltraPro QQQ

TQQQ is trending as traders navigate a broader market rotation driven by tech earnings and sensitivity to macroeconomic data, including shifting interest rate expectations and inflation reports. While some traders are expressing caution and taking profits on recent gains, others are actively deploying capital and using technical levels to capitalize on intraday volatility.

Robinhood GLD is a tokenized representation of SPDR Gold Shares (GLD) common stock, issued on Robinhood Chain, Robinhood's own blockchain built to bring tokenized real-world assets on-chain. Each token is designed to track the price of the underlying GLD share, giving holders on-chain price exposure to SPDR Gold Shares's stock. The token is freely transferable and composable across the Robinhood Chain ecosystem. It's part of Robinhood's broader initiative to expand access to tokenized U.S. equities via blockchain technology, alongside a wider lineup of tokenized stock tokens launching on the same network.

GoldCoin

GoldCoin is experiencing significant volatility and trading activity as traders debate its role as a potential safe-haven asset amid rising global economic uncertainties and central bank gold repatriation efforts. The community remains divided, with some participants viewing it as a hedge against inflation and sovereign debt concerns, while others characterize the price action as speculative or manipulative.

Seeker is building a decentralized mobile ecosystem designed to challenge entrenched mobile incumbents through its TEEPin network architecture and community governance. It aims to solve the pain points of centralized app store gatekeeping, lack of developer freedom, and restricted user access to crypto applications. The vision is to create a community-owned platform with decentralized governance, no gatekeepers, direct developer-user access, and TEEPin security architecture.

Seeker

Seeker (SKR) is trending as traders debate its potential as a Solana mobile-ecosystem play, with many focused on unverified reports of a pending Google Play Store app and an Agentnet system update. While some participants express frustration over recent price volatility and selling pressure, others are actively accumulating tokens in anticipation of future utility and adoption.

iShares Bitcoin Trust ETF (The) - iShares Bitcoin Trust Beneficial Interest

iShares Bitcoin Trust ETF

The conversation surrounding IBIT is driven by a mix of institutional accumulation and technical optimism following recent Bitcoin price strength, though investors remain cautious regarding macro headwinds and potential regulatory developments like the Clarity Act. Traders are debating whether the current move is a sustainable breakout or a bear market trap, with many closely watching ETF inflows and key technical resistance levels for further direction.

Samsara, Inc. develops internet connected sensor systems. It combines plug-and-play sensors, wireless connectivity, and cloud-hosted software integrated for deployment. The company was founded by John Bicket and Sanjit Biswas in 2015 and is headquartered in San Francisco, CA.

Samsara Inc - Ordinary Shares - Class A

Samsara Inc

Samsara shares surged following a strong fiscal second-quarter earnings report, where the company exceeded consensus estimates on both revenue and earnings while raising its full-year guidance. While community sentiment is bolstered by the firm's durable growth and adoption of AI-driven tools, some traders have expressed concerns regarding high valuations and potential profit-taking in the software sector.

Hedera is a decentralized public network where developers can build secure, fair applications with near real-time consensus. The platform is owned and governed by a council of global innovators including Avery Dennison, Boeing, Deutsche Telekom, DLA Piper, FIS (WorldPay), Google, IBM, LG Electronics, Magalu, Nomura, Swirlds, Tata Communications, University College London (UCL), Wipro, and Zain Group.   The Hedera Consensus Service (HCS) acts as a trust layer for any application or permissioned network and allows for the creation of an immutable and verifiable log of messages. Application messages are submitted to the Hedera network for consensus, given a trusted timestamp, and fairly ordered. Use HCS to track assets across a supply chain, create auditable logs of events in an advertising platform, or even use it as a decentralized ordering service.

Hedera Hashgraph

Hedera is trending as investors react to a mix of price stagnation and frustration, contrasted by long-term holders pointing to institutional infrastructure milestones like recent council additions and cross-ledger protocol developments as evidence of underlying value. Discussion remains fragmented between those dismissing the project as a poorly performing investment and others continuing to accumulate during what they characterize as a necessary consolidation phase.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

SMMT Stock Soars on NSCLC Drug Survival Data Beating Keytruda in China

Summit Therapeutics stock jumps 17% after ivonescimab showed a significant overall survival benefit over Keytruda in a China phase III lung cancer study.

IONS Secures FDA Nod for Rare Brain Disorder Drug Zanvastro

Ionis' FDA approval of Zanvastro marks the first disease-modifying treatment for Alexander disease and adds a priority review voucher.

Krystal Stock Gains 13.4% in a Month: What Is Driving the Rally?

KRYS' Vyjuvek growth and expanding genetic medicine pipeline boost investor confidence as the company advances toward multi-product growth.

FDA Accepts UTHR's sNDA for Tyvaso in Idiopathic Pulmonary Fibrosis

FDA accepts United Therapeutics' Tyvaso sNDA for an IPF label expansion, backed by TETON data showing improved lung function and reduced clinical worsening.

RARE Stock Down 46% as Phase III Angelman Syndrome Study Misses Goals

Ultragenyx plunges 46% after its phase III Angelman syndrome study fails to achieve key efficacy goals, putting apazunersen's future in question.

Here's Why You Should Add RNTX Stock to Your Portfolio Now

Rein Therapeutics advances LTI-03 in IPF. RENEW enrollment tops 25%, with interim data expected in the fourth quarter of 2026.

AZN's Tagrisso Plus Orpathys Study in First-Line NSCLC Meets Goal

AstraZeneca reports positive SANOVO data, showing Tagrisso plus Orpathys improved PFS in first-line EGFR-mutated NSCLC.

KURA Stock Gains 37.6% in a Month: Here's What You Need to Know

Kura's rising Komzifti sales, promising AML data and pipeline catalysts boost investor confidence and fuel KURA's gains.

BNTX Ends Colorectal Cancer Immunotherapy Study, Stock Down

BioNTech discontinues a phase II colorectal cancer study after updated data show an efficacy imbalance, while a pancreatic cancer study continues.

LLY's Mounjaro Gets FDA Nod to Cut Cardiovascular Risk in Diabetes

Eli Lilly's Mounjaro wins FDA approval to reduce cardiovascular risk in high-risk T2D patients, expanding its use and commercial opportunity.

$ACIU Q2 &#39;26 Earnings Results &amp; Recap

• Reported GAAP EPS of $0.03 up 111.54% YoY
• Reported revenue of $18.67M up 1031.52% YoY

Stocktwits

AC Immune SA

 Q2 '26 Earnings Results & Recap

• Reported GAAP EPS of $0.03 up 111.54% YoY
• Reported revenue of $18.67M up 1031.52% YoY

This account has been verified as an official STOCKTWITS representative.

Verified Account

Stocktwits Earnings

AC Immune SA is a clinical-stage biopharmaceutical company, which engages in the discovery and development of therapeutic and diagnostic products for neurodegenerative diseases. It leverages proprietary technology platforms to discover, design, and develop novel, proprietary medicines for prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding. The company was founded by Jean-Marie Lehn, Claude Nicolau, Roscoe Brady, Fred van Leuven, Ruth Greferath, Andrea Pfeifer, and Alexey V. Eliseev on February 13, 2003 and is headquartered in Lausanne, Switzerland.

ACIU Stock Heads For Best Day In Over 10 Months On FDA Fast Track Nod For Parkinson’s Disease Therapy – Retail Sees ‘Breakout Soon’

Equity

Bearish Sentiment

The Federal Reserve hasn't raised rates at all in 2026, but hawkish comments from Fed Chair Kevin Warsh at the Jackson Hole symposium have pushed September rate hike odds as high as 66%, a sharp jump from under 40% just a week earlier. How many rate hikes do you expect from the Fed in 2026? Vote and explain your reasoning in the comments.

How many rate hikes do you expect from the Fed in 2026?

Current Price	$2.86
Prev Close	$2.93
Open	$2.91
Dividend Yield	0.00%
50-Day Moving Average	$2.49
Beta	1.03
Avg. Volume	231,178.69
PE Ratio	-5.14

52-Week High	$4.00
52-Week Low	$2.10
Market Capitalization	$291.07M
EPS (Annual)	-$0.8419
Price to Book	5.98
Revenue Per Employee	$35,264.75

Feed

News

Sentiment

Earnings

Fundamentals

Info

ACIU Fundamentals